Back to links
Back to links
Back to links
Back to links
Collaborative Fund

The Collaborative Fund of the CGA was created in 2012 to provide a funding mechanism for projects that support the mission of the CGA-ICC.

Below is a description of the FUND including details on eligibility, submission instructions and deadline information. To download the Word version of the "Call for Proposals", click here.

The Collaborative Fund of the CGA is supported by the members of the CGA and through the generous, unrestricted matching grants of our industry sponsors:

COLLABORATIVE FUND OF THE CGA - CALL FOR PROPOSALS

Objective

The Collaborative Group of the Americas on Inherited Colorectal Cancer (CGA-ICC) is offering research or project awards that directly promote the mission of the organization. Proposals submitted for consideration should address one or more of the following:

1. To educate physicians and other healthcare professionals in the identification, molecular genetics and clinical management of
inherited CRC.

2. To enable or provide a mechanism of communication for the dissemination or exchange of data, discussion of controversial areas involved in the care of patients and their families with inherited colorectal cancer syndromes.

3. To facilitate collaborative studies involving multiple institutions that focus on inherited CRC.

4. To address issues concerning patients and families with inherited colorectal cancer that is of particular interest to the public and healthcare providers of the Americas.

5. To improve multidisciplinary expertise in clinical care, healthcare policy and research related to inherited colorectal cancer (CRC).

Description

Awards of up to $20,000 will be given to unique and creative projects based on competitive review. Preliminary or pilot projects do not require previous work or preliminary data. These awards are not designed to fund ongoing activities or laboratory based studies. Grants submitted with matching funds will receive special attention. The number of awards granted per year by the Collaborative Fund Committee will be determined in advance based on funds available. Each award will be for one year; however, competitive renewal for a second year is possible based on documentation of productivity and availability of funds.

Eligibility Requirements

  • The proposed research or activity must be director or investigator-initiated and conducted within North, Central, or South America
  • All active members of the CGA-ICC, regardless of the degree or title, are encouraged to submit
  • Members of the CGA-ICC Executive Council or Collaborative Fund Committee are ineligible for this award
  • Investigators may submit one application per funding cycle
  • Award Provisions:

  • The awarding of a grant, or renewal of an existing grant, is at the discretion of the Collaborative Fund Committee and can be suspended from year to year.
  • All or part of a submitted proposal cannot be funded by another institution or agency, either local or national other than in the form of a matching grant. When tied to a matching grant, funding of the Collaborative Fund award is contingent on successful funding of the matching grant.
  • The submitting investigator/organizer agrees to complete the project based on the specific aims and budget submitted.
  • Salary support for the investigator(s), travel funds or institutional indirect costs are not allowed.
  • A progress report will be submitted at the end of the sixth month of funding to the Collaborative Fund Committee with a final report being submitted within three months of completion of the grant period.
  • Successful applicants must agree to acknowledge CGA-ICC Collaborative Fund support in any publications or presentations that result from the research or project.
  • All awards will be recognized at the annual meeting. One or more of the investigators participating in the project are required to present their findings or outcomes of the project to the CGA-ICC membership at the annual meeting. To facilitate this presentation, the principal investigator or their designate will be offered complementary meeting registration for the meeting in which they present their project.
  • Application Deadline

    Completed applications (as defined below) must be received by 5:00 PM EST, Friday July 28, 2017.

    In evaluating the merits of an application, the Committee will consider the following:

  • The nature and clarity of the project as a discrete, well defined activity that can be completed within the proposed study period
  • Clinical or scientific significance or relevance of the project as it pertains to the field of inherited colorectal cancer syndromes
  • Number of individuals or institutions that will benefit from the proposal
  • Availability of other resources to fund the proposal
  • Ability of the investigator(s) to complete the Specific Aims or objectives of the proposal
  • Project feasibility (including availability of adequate resources, personnel, and facilities) and measures of outcome
  • Instructions for Submission:

    Applications are required to include the following elements. Documents should be formatted using 1" margins and a font no smaller than 11 point with a limit of 10 pages.


    FAILURE TO ADHERE TO THESE INSTRUCTIONS WILL CAUSE THE GRANT APPLICATION TO BE RETURNED WITHOUT REVIEW.

    Applications can be submitted by E-mail as a PDF with signature sheets by mail or email.
    E-mail submissions: steven.erdman@nationwidechildrens.org

    Mail:
    Steven H. Erdman, MD
    Division of Gastroenterology, Hepatology and Nutrition
    Nationwide Children's Hospital
    700 Children's Drive
    Columbus, OH 43205-2664

    ALL sections below are counted in the 10 page limit

  • Cover Page: To download the Cover Page, please click here. If you have questions regarding the form please contact Word Dr. Erdman Steven.Erdman@nationwidechildrens.org.
  • Summary Statement
  • Background/Significance, Hypothesis, and Specific Aims
  • Briefly review background material for the proposal while critically evaluating existing knowledge, and present the significance of the topic. Clearly and concisely state the hypothesis to be tested and/or what the project is intended to accomplish.
  • Research Plan (maximum 3 pages)
  • Rationale
  • Project/Experimental Design
  • Planned Analysis/Statistics
  • Expected Outcomes
  • Pitfalls and Alternative Approaches
  • Resources Available and Feasibility to Complete Research
  • References Cited
  • List all citations of literature at the end of the research plan, in the order in which they are cited in the proposal. Each complete citation must include the names of all authors, the complete title of any article, the name of the book or journal, volume number, page numbers, and year of publication.
  • Institutional Review Board (IRB) status
  • If the proposal involves the participation of human subjects, this section MUST include either a draft of the consent form or the IRB-approved study consent forms; or (if applicable) institutional review board approval for the use of human subjects. Please note IRB approval is required before release of funding, but IRB approval is not required at the time of proposal submission.
  • Conflict of interest
  • all applications should consider and address conflict of interest issues regarding copyright materials (device and drug patents) as necessary.
  • Budget
  • A proposal budget should be prepared as a separate document. Indicate how the funds will be allocated and justify each budget item.
  • The Sections below items are excluded from the 10 page limit

  • Supporting Letters:
    A letter of support from the home sponsoring institution indicating their willingness to provide necessary administrative assistance as well as time and financial support to present at the CGA-ICC national meeting is required. Provide letters of support from all collaborators particularly if multiple institutions are involved.
  • Biographical Sketch for Primary Investigator and Co-investigators (NIH format or similar limited to 3 pages)